TEOFIL Deep 1.1 ml
TEOFIL (Teofil)
Medical device — hyaluronic acid dermal fillerMonophasic HA dermal filler for medium-to-deep dermis / volume restoration
Certifications
- CE certified (manufacturer brochure explicitly states CE certification for TEOFIL family).
- Manufacturer claims ISO 13485 quality management compliance.
- Manufacturer states HCCL™ manufacturing process and in House clinical testing (clinical trial data summarised in manufacturer brochure).
- CE certified (manufacturer brochure explicitly states CE certification for TEOFIL family).
- Manufacturer claims ISO 13485 quality management compliance.
- Manufacturer states HCCL™ manufacturing process and in House clinical testing (clinical trial data summarised in manufacturer brochure).
Monophasic HA dermal filler for medium-to-deep dermis / volume restoration
Description
TEOFIL Deep is a CE-certified, monophasic cross-linked hyaluronic acid (HA) filler manufactured using HCCL™ (Highly Completed Cross-Linking) technology. Formulated as a viscous, elastic gel for medium-to-deep dermal injection, Deep is intended to correct deeper folds, restore lost facial volume and enable lip augmentation. The product is supplied in a prefilled syringe (1.1 ml) and includes lidocaine for patient comfort.
Bnefits
- Monophasic gel structure for consistent texture and smooth integration
- HCCL™ advanced cross-linking technology (manufacturer claim) for stabilized 3D matrix and enhanced rheological properties
- Contains lidocaine (0.3%) to improve injection comfort
- 20 mg hyaluronic acid per ml concentration for volumising and hydrating effect
- Packaged as ready-to-use prefilled syringe (1.1 ml) with needles included per product summary
- CE marked and produced under ISO 13485 processes per manufacturer literature
Indications
- Correction of deep facial folds and restoration of facial volume (e.g., nasolabial folds)
- Lip augmentation and lip volumising
- Facial contouring where medium-to-deep dermal placement is clinically indicated
Composition
- Cross-linked hyaluronic acid (HA) — 20 mg/ml as stated in manufacturer product literature
- Lidocaine — 0.3% (stated in product summary)
- Cross-linking performed using HCCL™ technology (manufacturer description; exact cross-linker residuals not published)
Formulation
- Monophasic hyaluronic acid gel with enhanced viscoelasticity intended for injection into medium-to-deep dermis
- Supplied as 1 x 1.1 ml prefilled syringe (Deep variant) with needles included (manufacturer product summary lists 1 x 25G needle and 1 x 27G needle)
- Sterile, single-use injectable device
Packaging
- Typical pack: 1 x 1.1 ml prefilled syringe (Deep) in sterile single-use packaging; carton and leaflet included (pack contents listed in manufacturer brochure)
- Needles included in the pack per product summary (exact needle gauges listed in manufacturer brochure)
Usage
- For professional use only by qualified practitioners trained in injectable dermal fillers (manufacturer and distributor pages state professional use requirement).
- Follow aseptic technique and local protocols for injection depth and technique; Deep is described for medium-to-deep dermal placement and lip augmentation per manufacturer guidance.
- Use appropriate needle/cannula sizes as per product IFU and practitioner judgement; massage and aftercare per clinician protocol.
- Inspect product packaging for integrity prior to use and follow local sharps disposal and handling regulations.
Contraindications
Not publicly listed
Adverse Effects
Not publicly listed
Storage Conditions
- Manufacturer/distributor product literature and listings reference standard storage: keep in original packaging, protect from extreme temperatures and direct sunlight; consult product labelling/IFU for exact storage temperature range.
Duration
Not publicly listed
Onset
Not publicly listed
| Price | Link |
|---|---|
| £16.49 | https://www.lpgclinicswholesale.com/product/teofil-deep/ |
